Skip to Content
Merck
All Photos(2)

Documents

GF52084346

Thulium

foil, 25x25mm, thickness 0.15mm, as rolled, 99%

Synonym(s):

Thulium, TM000215

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
Tm
CAS Number:
7440-30-4
Molecular Weight:
168.93
MDL number:
MFCD00011281
UNSPSC Code:
12141615
PubChem Substance ID:
329807870
NACRES:
NA.23

Assay

99%

form

foil

manufacturer/tradename

Goodfellow 520-843-46

resistivity

90 μΩ-cm, 20°C

size × thickness

25x25 mm × 0.15 mm

bp

1950 °C (lit.)

mp

1545 °C (lit.)

density

9.332 g/mL at 25 °C (lit.)

SMILES string

[Tm]

InChI

1S/Tm

InChI key

FRNOGLGSGLTDKL-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Kun Tang et al.
Journal of endourology, 28(1), 65-72 (2013-08-29)
To assess the efficacy and safety of thulium laser resection of the prostate (TmLRP) vs transurethral resection of the prostate (TURP) for treating patients with benign prostatic hyperplasia (BPH). A systematic search of the electronic databases, including Medline, Scopus, China
Amedeo Calisto et al.
Journal of neurosurgery. Pediatrics, 14(6), 563-572 (2014-10-18)
Hypothalamic hamartomas (HH) may induce drug-resistant epilepsy (DRE), thereby requiring surgical treatment. Conventionally, treatment is aimed at removing the lesion, but a disconnection procedure has been shown to be safer and at least as effective. The thulium laser (Revolix) has
T Bach et al.
World journal of urology, 28(2), 163-168 (2010-03-06)
Tm:YAG 2 mum cw laser prostatectomy was introduced in the treatment of benign ptostatic obstruction (BPO). Since then numerous studies have been published proving efficacy during follow-up. However, different surgical techniques were introduced with different names for similar techniques that
Li Li et al.
Journal of nanoscience and nanotechnology, 14(6), 4313-4319 (2014-04-18)
Lutetium oxide nanocrystals codoped with Tm3+ and Yb3+ have been successfully synthesized via adjusting the pH values of the precursor solution in a hydrothermal method followed by a subsequent calcination process. The samples were systematically characterized by X-ray diffraction, field-emission
Giovanni Muto et al.
Urology, 83(4), 851-855 (2014-02-20)
To determine whether thulium:yttrium-aluminum-garnet laser resection of bladder tumor (TmLRBT) may offer advantages over classic resection. From April 2011 to September 2012, 55 consecutive patients newly diagnosed with clinical stage ≤T2 bladder cancer were enrolled in a prospective study on TmLRBT.
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service